Companies / Santa Cruz Biotechnology / CD133 CRISPR/Cas9 KO Plasmid (m)
Santa Cruz Biotechnology

CD133 CRISPR/Cas9 KO Plasmid (m) | Santa Cruz Biotechnology

CRISPR/Cas9 Knockout (KO) Plasmids consist of a pool of three plasmids each encoding the Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.